{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:47:32Z","timestamp":1790380052878,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1002\/jps.21993","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T17:08:10Z","timestamp":1257440890000},"page":"2320-2332","source":"Crossref","is-referenced-by-count":35,"title":["Self-emulsifying O\/W formulations of paclitaxel prepared from mixed nonionic surfactants"],"prefix":"10.1016","volume":"99","author":[{"given":"Jen-Ting","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzer-Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.21993_bb0010","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1021\/np8006556","article-title":"Recent advances in the chemistry and biology of new generation taxoids","volume":"72","author":"Ojima","year":"2009","journal-title":"J Nat Prod"},{"key":"10.1002\/jps.21993_bb0015","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2217\/14622416.8.7.803","article-title":"Pharmacology, pharmacokinetics and pharmacogenomics of paclitaxel","volume":"8","author":"Steed","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1002\/jps.21993_bb0020","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/annonc\/mdj100","article-title":"Novel formulations of taxanes: A review. Old wine in a new bottle?","volume":"17","author":"Hennenfent","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1002\/jps.21993_bb0025","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1023\/B:PHAM.0000041451.70367.21","article-title":"Design and evaluation of an emulsion vehicle for paclitaxel. I. Physiochemical properties and plasma stability","volume":"21","author":"Han","year":"2004","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21993_bb0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jbm.a.10481","article-title":"Enhanced solubility of paclitaxel using water-soluble and biocompatible 2-methacryloyloxyethyl phosphorylcholine polymers","volume":"65A","author":"Konno","year":"2003","journal-title":"J Biomed Mater Res A"},{"key":"10.1002\/jps.21993_bb0035","unstructured":"Taxol\u00ae (paclitaxel) injection, Bristol-Myers Squibb Company, Princeton, NJ,2003."},{"key":"10.1002\/jps.21993_bb0040","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/jps.10511","article-title":"Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability","volume":"92","author":"Gao","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21993_bb0045","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1016\/j.ces.2007.08.006","article-title":"Chemotherapeutic engineering: Vitamin E TPGS-emulsified nanoparticles of biodegradable polymers realized sustainable paclitaxel chemotherapy for 168 h in vivo","volume":"62","author":"Feng","year":"2007","journal-title":"Chem Eng Sci"},{"key":"10.1002\/jps.21993_bb0050","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/jps.21487","article-title":"Lung-specific delivery of paclitaxel by chitosan-modified PLGA nanoparticles via transient formation of microaggregates","volume":"98","author":"Yang","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21993_bb0055","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1007\/s11095-008-9674-4","article-title":"Surface modification of pharmaceutical nanocarriers with ascorbate residues improves their tumor-cell association and killing and the cytotoxic action of encapsulated paclitaxel in vitro","volume":"25","author":"D'Souza","year":"2008","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21993_bb0060","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/jps.21111","article-title":"Development of nonsurfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel","volume":"97","author":"Bilensoy","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21993_bb0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jconrel.2008.09.086","article-title":"Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation","volume":"133","author":"Danhier","year":"2009","journal-title":"J Controlled Release"},{"key":"10.1002\/jps.21993_bb0070","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11095-007-9451-9","article-title":"Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: Pharmacokinetic disposition, tolerability, and cytotoxicity","volume":"25","author":"Forrest","year":"2008","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21993_bb0075","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.biomaterials.2008.12.083","article-title":"Thermosensitive poly(organophosphazene)-paclitaxel conjugate gels for antitumor applications","volume":"30","author":"Chun","year":"2009","journal-title":"Biomaterials"},{"key":"10.1002\/jps.21993_bb0080","series-title":"Taxol\u00ae: Science and applications","author":"Suffness","year":"1995"},{"key":"10.1002\/jps.21993_bb0085","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.biomaterials.2006.12.018","article-title":"Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery","volume":"28","author":"Zhang","year":"2007","journal-title":"Biomaterials"},{"key":"10.1002\/jps.21993_bb0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.biomaterials.2007.09.038","article-title":"Multifunctional poly(D,L-lactide-co-glycolide)\/montmorillonite (PLGA\/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer","volume":"29","author":"Sun","year":"2008","journal-title":"Biomaterials"},{"key":"10.1002\/jps.21993_bb0095","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1023\/A:1016483406511","article-title":"A new parenteral emulsion for the administration of Taxol","volume":"4","author":"Tarr","year":"1987","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21993_bb0100","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(98)00164-3","article-title":"Development of nonionic surfactant\/phospholipid O\/W emulsion as a paclitaxel delivery system","volume":"58","author":"Kan","year":"1999","journal-title":"J Controlled Release"},{"key":"10.1002\/jps.21993_bb0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0927-7765(99)00048-X","article-title":"Study on the formulation of O\/W emulsion as carriers for hydrophobic drugs","volume":"15","author":"Kan","year":"1999","journal-title":"Colloids Surf B"},{"key":"10.1002\/jps.21993_bb0110","first-page":"170","article-title":"Emulsion formulation for intravenous administration of paclitaxel","volume":"52","author":"Simamora","year":"1998","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1002\/jps.21993_bb0115","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/02652049009021832","article-title":"In vitro and in vivo antitumoral activity of free and encapsulated Taxol","volume":"7","author":"Bartoli","year":"1990","journal-title":"J Microencapsul"},{"key":"10.1002\/jps.21993_bb0120","first-page":"3494","article-title":"Tributyrin: A prodrug of butyric acid for potential clinical application in differentiation therapy","volume":"54","author":"Chen","year":"1994","journal-title":"Cancer Res"},{"key":"10.1002\/jps.21993_bb0125","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0939-6411(98)00037-X","article-title":"Increasing drug solubility by means of bile salt-phosphatidylcholine-based mixed micelles","volume":"46","author":"Hammad","year":"1998","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.21993_bb0130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0005-2736(91)90182-8","article-title":"Large liposomes containing gangloiside gm1 accumulate effectively in spleen","volume":"1066","author":"Liu","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/jps.21993_bb0135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0169-409X(99)00041-1","article-title":"The size of liposomes: A factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs","volume":"40","author":"Nagayasu","year":"1999","journal-title":"Adv Drug Deliver Rev"},{"key":"10.1002\/jps.21993_bb0140","series-title":"Surfactant and interfacial phenomena","author":"Rosen","year":"2004"},{"key":"10.1002\/jps.21993_bb0145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/01932699008943238","article-title":"Predicting O\/W emulsion stability by the \u201cRequired HLB Equation\u201d","volume":"11","author":"Vaughan","year":"1990","journal-title":"J Disper Sci Technol"},{"key":"10.1002\/jps.21993_bb0150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/bjc.1992.217","article-title":"Reversal of multidrug resistance by surfactants","volume":"66","author":"Woodcock","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1002\/jps.21993_bb0155","unstructured":"Andersson BJ.1999. Parenteral paclitaxel in a stable non-toxic formulation, US Patent5,877,205."},{"key":"10.1002\/jps.21993_bb0160","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/la0520029","article-title":"Modification of gold nanorods using phospatidylcholine to reduce cytotoxicity","volume":"22","author":"Takahashi","year":"2006","journal-title":"Langmuir"},{"key":"10.1002\/jps.21993_bb0165","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1002\/jps.21591","article-title":"Topical vehicles based on natural surfactant\/fatty alcohols mixed emulsifier: The influence of two polyols on the colloidal structure and in vitro\/in vivo skin performance","volume":"98","author":"Savic","year":"2009","journal-title":"J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915326381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915326381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T13:21:43Z","timestamp":1558617703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915326381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0022354915326381"],"URL":"https:\/\/doi.org\/10.1002\/jps.21993","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}